Pediatrics, Critical Care Medicine
-
-
Administers Grant
-
7 day study of the safety, efficacy and the pharmacokinetic and pharmacodyamic properties of oral rivaroxaban in children from birth to less than 6 months with catheter-related aterial or venous thrombosis
-
A Phase 1b, Multicenter, double blind randomized controlled dose escalating trial
of fentanyl vs. fentanyl + dexmedetomidine as the initial regimen for maintenance
of sedation in mechanically-ventilated, critically ill children
-
A Phase 2/3 Randomized, Openn-Label, Multi-center Study to Determine the Safety and Efficacy of Solithromycin in Adolescents (12 to17 years of age, inclusive) and Children (>- 2 months to < 12 years of age) with Suspected or Confirmed Community
-
A Phase 3, Multicenter, open-label, randomized, comparator controlled trial of the safety and efficacy of dalbavancin versus active comparator in pediatric subjects with acute bacterial skin and skin structure infections.
-
A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A; IRC-005
-
ARDS in Children and ECMO initiation strategies impact on Neuro-Development (ASCEND)
-
CAZ-AVI (Ceftazidime-Avibactam)
-
Clinical Pharmacokinetics and Safety Trials in Down Syndrome
-
HALF-PINT: Heart and Lung Failure - Pediatric INsulin Titration trial - CCC
-
Mechanisms of Intracellular Iron Accumulation in Cystic Fibrosis
-
Oxycontin Drug Utilization in Children
-
POP V (Duke 08) TO 49
-
PROSpect - Prone and Oscillation Pediatric Clinical Trial
-
Pediatric Critical Care Research Landscape - A National Expert Conference
-
Pharmacokinetics and Safety Profile of Digoxin in Infants with Single Ventricle Congenital Heart Disease
-
Pharmacokinetics and Safety of Anesthetics and Analgesics in Children
-
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
-
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
-
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
-
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
-
Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months with Suspected or Confirmed Bacterial Infection
-
Pharmacokinetics of ant-epileptic Drugs in Obese Children (HHSN-275201000003I)
-
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POPS)
-
Real World Data to Support Pediatric Drug Labeling
-
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
-
Understanding COVID-19 among critically ill children in the Pediatric Acute Lung Injury and Sepsis Investigator's (PALISI) Network